We are live on ! Find out more
Chevy Chase Trust

Chevy Chase Trust Portfolio holdings

AUM $34.7B
1-Year Est. Return 29.45%
This Fund
S&P 500
This Quarter Est. Return
+22.49%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+525.93%
AUM
$24.7B
AUM Growth
+$3.17B
Cap. Flow
-$1.16B
Cap. Flow %
-4.72%
Top 10 Hldgs %
26.96%
Holding
661
New
31
Increased
56
Reduced
513
Closed
20

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$73.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$27.2M
3
DXCM icon
DexCom
DXCM
+$26.6M
4
TMUS icon
T-Mobile US
TMUS
+$18.9M
5
ASML icon
ASML
ASML
+$18.5M

Sector Composition

Rank Sector Weight
1 Technology 24.7%
2 Healthcare 15.1%
3 Financials 12.84%
4 Communication Services 10.4%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$318B
$165M 0.67%
2,236,561
-161,672
-7% -$12.2M
NFLX icon
27
Netflix
NFLX
$309B
$162M 0.66%
3,562,210
-186,360
-5% -$7.93M
CSCO icon
28
Cisco
CSCO
$479B
$162M 0.66%
3,473,749
-198,909
-5% -$8.72M
ACN icon
29
Accenture
ACN
$108B
$162M 0.66%
754,058
+25,033
+3% +$4.73M
XOM icon
30
ExxonMobil
XOM
$634B
$160M 0.65%
3,572,151
-188,922
-5% -$8.47M
PFE icon
31
Pfizer
PFE
$153B
$151M 0.61%
4,877,553
-245,192
-5% -$8.33M
BAC icon
32
Bank of America
BAC
$442B
$151M 0.61%
6,357,069
-601,671
-9% -$14.2M
KO icon
33
Coca-Cola
KO
$375B
$147M 0.6%
3,292,504
-178,391
-5% -$8.22M
ABBV icon
34
AbbVie
ABBV
$435B
$147M 0.6%
1,496,542
+166,521
+13% +$14.7M
CMCSA icon
35
Comcast
CMCSA
$90B
$144M 0.58%
3,696,293
-194,928
-5% -$7.42M
WMT icon
36
Walmart Inc
WMT
$890B
$138M 0.56%
3,461,979
-198,459
-5% -$8.16M
CVX icon
37
Chevron
CVX
$366B
$137M 0.55%
1,532,722
-107,860
-7% -$9.66M
CRM icon
38
Salesforce
CRM
$158B
$136M 0.55%
727,155
-28,869
-4% -$4.86M
ABT icon
39
Abbott
ABT
$187B
$136M 0.55%
1,482,221
-78,483
-5% -$7.09M
COST icon
40
Costco
COST
$420B
$132M 0.54%
435,940
+1,161
+0.3% +$353K
LMT icon
41
Lockheed Martin
LMT
$136B
$119M 0.48%
324,776
-12,338
-4% -$4.66M
ECL icon
42
Ecolab
ECL
$79.9B
$118M 0.48%
595,424
-13,940
-2% -$2.7M
LLY icon
43
Eli Lilly
LLY
$1.06T
$118M 0.48%
719,633
-40,433
-5% -$6.21M
TMO icon
44
Thermo Fisher Scientific
TMO
$220B
$116M 0.47%
321,165
-22,860
-7% -$7.66M
ROP icon
45
Roper Technologies
ROP
$39.8B
$116M 0.47%
299,076
+1,853
+0.6% +$664K
ISRG icon
46
Intuitive Surgical
ISRG
$134B
$116M 0.47%
610,653
-16,593
-3% -$2.97M
GS icon
47
Goldman Sachs
GS
$303B
$115M 0.47%
583,804
+18,645
+3% +$3.5M
EL icon
48
Estee Lauder
EL
$32B
$115M 0.47%
611,125
-7,328
-1% -$1.31M
MCD icon
49
McDonald's
MCD
$195B
$115M 0.47%
623,776
-42,474
-6% -$7.79M
AMGN icon
50
Amgen
AMGN
$222B
$115M 0.47%
486,466
-31,723
-6% -$7.24M

Similar funds

Chevy Chase Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Chevy Chase Trust held 661 positions worth $24.7B, up 15% from $21.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Chevy Chase Trust withdrew a net $1.16B in Q2 2020, closing 20 positions and reducing 513 holdings. Its most notable exit was Allergan plc, an estimated $49.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Chevy Chase Trust opened a new position in DexCom worth $30.1M.

  • Chevy Chase Trust's largest Q2 2020 buy was DexCom: 297,088 shares worth $30.1M.
  • Chevy Chase Trust added most to RTX Corp in Q2 2020, an estimated $73.5M increase.
  • Chevy Chase Trust's biggest Q2 2020 reduction was Apple, cutting an estimated $87.1M.
  • Chevy Chase Trust fully exited Allergan plc in Q2 2020, selling an estimated $49.5M.
  • Chevy Chase Trust's ten largest holdings make up 27% of its $24.7B portfolio in Q2 2020.
  • Chevy Chase Trust opened 31 new positions and closed 20 in Q2 2020.
  • Chevy Chase Trust's portfolio value rose 15% quarter-over-quarter to $24.7B.

Based on Chevy Chase Trust's 13F filing for Q2 2020, filed 14 Aug 2020.